An oncogenic fusion protein, paxillin-3-forkhead (PAX3-FKHR) interacts with STAT3 to alter the transcription of various immune-stimulating cytokines and chemokines, and MHC class II molecules in tumor cells. This evidence concerns the gene STAT3 and neoplasm.